<DOC>
	<DOCNO>NCT02689479</DOCNO>
	<brief_summary>In people type I diabetes , insulin produce cell pancreas destroy . Presently one evaluate function graft laboratory test , blood sugar insulin requirement . The mass insulin produce cell location know . The possibility study mass insulin produce cell importance develop new treatment regime , order evaluate efficacy parameter . The researcher study aim develop method measure mass insulin produce cell . A method ( positron emission tomography , PET ) previously use diagnosis tumor insulin produce cell may also use measure amount insulin produce cell patient type I diabetes . They plan evaluate participant type 1 diabetes undergone islet transplantation , evaluate PET used measure beta cell mass islet transplantation .</brief_summary>
	<brief_title>11C-5-HTP PET Clinical Islet Transplantation</brief_title>
	<detailed_description />
	<mesh_term>5-Hydroxytryptophan</mesh_term>
	<criteria>Subjects must meet follow criterion consider eligible participation study : 1 . Subjects able provide write informed consent comply procedure study protocol . 2 . Patient receive islet transplant outside CIT01 trial ( post primary endpoint ) . Subjects meet criterion eligible participation study : 1 . For female subject : Positive serum pregnancy test , presently breastfeed , unwillingness use effective contraceptive measure time PET scan +/ 2 week . 2 . Known history severe coexist cardiac disease , characterize one follow condition : 1 . Recent myocardial infarction ( within past 6 month ) . 2 . Evidence ischemia functional cardiac exam within last year . 3 . Left ventricular ejection fraction &lt; 30 % . 3 . Persistent elevation liver function test time study entry . Persistent Aspartate Aminotransferase ( serum glutamicoxaloacetic transaminase ) , Alanine Aminotransferase ( serum glutamate pyruvate transaminase ) , Alkaline phosphatase total bilirubin , value &gt; 1.5 time normal upper limit exclude patient . 4 . Treatment antidiabetic medication , insulin , within 4 week enrollment . 5 . Use investigational agent within 4 week enrollment . 6 . Any medical condition , opinion investigator , interfere safe completion trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Clinical Islet Transplantation</keyword>
	<keyword>Positron Emission Tomography ( PET ) Computed Tomography ( CT ) imaging</keyword>
</DOC>